Review article · 2015
Conference abstractPublished 19 Jun 2017
Fibrous cephalic plaques in tuberous sclerosis complex
National Institutes of Health, USA; Uniformed Services University of the Health Sciences, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Fibrous cephalic plaques (FCPs) prototypically develop on the forehead of patients with tuberous sclerosis complex (TSC). They constitute a major feature for the diagnosis of TSC, and may be present before other TSC-related cutaneous hamartomas. We aimed to describe the clinical characteristics of FCPs in TSC. 115 adult patients with TSC were enrolled in an observational cohort study. A retrospective analysis of medical records and skin photography was performed. FCPs were categorized per anatomic location and size. Overall, 36% (41/115) of patients had at least one FCP on the scalp, face, or neck. 61 total lesions from the 41 patients were classified according to size; 57% 1 to <5 cm, 13% âÂ?¥5 cm, and 26% unknown due to prior excision. The distribution of lesions was 35% scalp, 37% forehead, 23% face (non-forehead) and 5% neck. The lesions showed a left-sided predilection; 61% left sided versus 28% right sided and 10% midline. Of the 11 lesions that were histopathologically analyzed, most were characterized by dermal collagenosis with marked decrease of dermal elastic fibers. Only about one-third of FCPs was present on the classic location of the forehead, with the remainder split between other locations on the face or scalp. Better recognition of these lesions by clinicians may lead to earlier diagnosis of TSC.
Subjects
DermatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 5 Mar 2012
Tuberous sclerosis complex the systemic manifestations in pediatric patients experience in México
Opinion · 30 Jun 2023
Counterfeit Medications: A Growing Threat to Tuberous Sclerosis Management
Commentary · 11 Nov 2022
Tuberous Sclerosis and Fake Medicine: Dermatological and Genetic Evidence
Commentary · 16 May 2022
Dermatological and Genetic Data in Tuberous Sclerosis and Counterfeit Medications
More from this journal
The newest in Journal of Clinical & Experimental Dermatology Research.
Research article · 30 Jul 2026
MINIMALLY-INVASIVE LASER-ASSISTED (MILA) FACELIFT UNDER LOCAL ANESTHESIA
Commentary · 30 Jul 2026
Breaking the Stigma Around Psoriasis: A Broader View of Chronic Skin Disease
Perspective · 28 Jul 2026
Acne as More Than a Cosmetic Concern: A Personal and Medical Perspective
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical & Experimental Dermatology Research
- SubjectDermatology
- BylineArticles whose byline prints “Oyetewa Oyerinde”
- BylineArticles whose byline prints “Danielle Buccine”
- BylineArticles whose byline prints “Joel Moss”
- BylineArticles whose byline prints “Thomas N Darling”

